Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Arch Inst Cardiol Mex ; 70(2): 160-6, 2000.
Artigo em Espanhol | MEDLINE | ID: mdl-10932801

RESUMO

The efficacy and safety of intravenous propafenone for conversion of recent-onset and chronic atrial fibrillation was assessed in 46 patients. 40 with atrial fibrillation associated with or without structural heart disease (mean age 63 +/- 14 years) and 6 patients with atrial fibrillation related to the Wolff-Parkinson-White syndrome (mean age 34.8 +/- 13 years). Propafenone treatment was administered at 2 mg/kg over 15 minutes under continuous electrocardiographic monitoring. In 28 of 32 (87.5%) patients with paroxysmal and/or recent-onset atrial fibrillation a stable sinus rhythm was restored within 1 hour after propafenone (mean 17 +/- 11 minutes) and in only 3 of 8 (37.5%) with chronic atrial fibrillation (p < 0.05). Conversion to sinus rhythm was obtained in 5 of 6 (83.3%) patients with atrial fibrillation related ventricular preexcitation, mean time 21 +/- 12 minutes. Propafenone had an additional effect reducing mean heart rate (141 +/- 21 to 102 +/- 15 beat per minute, p < 0.05) and the shortest preexcited R-R intervals was increased, mean 231.6 +/- 27.8 to 355 +/- 37.2 milliseconds (p < 0.001) in cases associated with ventricular preexcitation. Dizziness, hypotension and transient conduction disturbances occurred in only one patient with rheumatic valvular heart disease: EF 40%. Propafenone is an effective and safe antiarrhythmic drug for converting paroxysmal and/or recent-onset atrial fibrillation of various origins with a more limited efficacy in chronic atrial fibrillation.


Assuntos
Antiarrítmicos/administração & dosagem , Fibrilação Atrial/tratamento farmacológico , Propafenona/administração & dosagem , Idoso , Fibrilação Atrial/complicações , Interpretação Estatística de Dados , Feminino , Humanos , Infusões Intravenosas , Masculino , Pessoa de Meia-Idade , Fatores de Tempo , Síndrome de Wolff-Parkinson-White/complicações
2.
Arch Inst Cardiol Mex ; 68(6): 498-505, 1998.
Artigo em Espanhol | MEDLINE | ID: mdl-10365226

RESUMO

Torsade de Pointes (TdP) is an atypical ventricular tachycardia that occurs in the setting of QT interval prolongation which may be an inherited or acquired abnormality. TdP is a recognized complication of bradyarrhythmias, specifically atrioventricular block. However, sinus node dysfunction is a rare cause of syncope associated with TdP. Experimental studies have suggested that the acquired long QTU interval and TdP may be due to bradycardia or pause-dependent early after depolarizations that give rise to triggered activity. This report describes a patient with sinus bradycardia and intermittent AV nodal rhythm induced long QT interval and repetitive syncope related to TdP and successfully treated with temporal and long-term pacing.


Assuntos
Nó Sinoatrial/fisiopatologia , Síncope/etiologia , Torsades de Pointes/complicações , Idoso , Arritmia Sinusal/complicações , Arritmia Sinusal/fisiopatologia , Eletrocardiografia , Feminino , Humanos , Torsades de Pointes/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA